-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007_MaskedStats_IP.PDF
January 01, 2007 - 0.02
106: CORONARY BYPASS W PTCA 731 0.02
108: OTHER CARDIOTHORACIC PROCEDURES 678 0.02
110: MAJOR CARDIOVASCULAR … PROCEDURES W CC 5,555 0.17
111: MAJOR CARDIOVASCULAR PROCEDURES W/O CC 458 0.01
113: AMPUTATION FOR … CV DX 4,868 0.15
554: OTHER VASCULAR PROCEDURES W CC W/O MAJOR CV DX 5,414 0.17
555: PERCUTANEOUS CARDIOVASCULAR … PROC W DRUG-ELUTING STENT W MAJOR CV DX 16,625 0.52
558: PERCUTANEOUS CARDIOVASCULAR PROC W DRUG-ELUTING … procedures 3,011 0.07
63: Other non-OR therapeutic cardiovascular procedures 11,468 0.27
64: Bone
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Jz4WcZ2Wy3-nV6jNUrwUzX
June 20, 2017 - Refer to USPSTF Procedure Manual for
further details.10 BMI indicates bodymass index; CV, cardiovascular … Cardiovascular
disease risk in healthy children and its association
with bodymass index: systematic … Insulin
resistance and cardiovascular risk factors in 3- to
5-year-old overweight or obese children … Prevalence of
cardiovascular disease risk factors among US
adolescents, 1999-2008. … Long-term follow-up of cardiovascular disease risk
factors in children after an obesity intervention
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2009_MaskedStats_Core_Weighted.PDF
January 01, 2009 - PROCEDURES W CC 5,202 0.07%
111: MAJOR CARDIOVASCULAR PROCEDURES W/O CC 1,616 0.02%
113: AMPUTATION … Percent
of Total
554: OTHER VASCULAR PROCEDURES W CC W/O MAJOR CV DX 1,048 0.01%
555: PERCUTANEOUS CARDIOVASCULAR … 556: PERCUTANEOUS CARDIOVASC PROC W NON-DRUG-ELUTING STENT W/O MAJ CV DX 61 0.00%
557: PERCUTANEOUS CARDIOVASCULAR … PROC W DRUG-ELUTING STENT W MAJOR CV DX <= 50 *.**%
558: PERCUTANEOUS CARDIOVASCULAR PROC W DRUG-ELUTING … procedures 814 0.01%
63: Other non-OR therapeutic cardiovascular procedures 1,488 0.02%
64: Bone marrow
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007v2_MaskedStats_IP.PDF
April 09, 2010 - 0.02
106: CORONARY BYPASS W PTCA 710 0.02
108: OTHER CARDIOTHORACIC PROCEDURES 659 0.02
110: MAJOR CARDIOVASCULAR … PROCEDURES W CC 5,575 0.18
111: MAJOR CARDIOVASCULAR PROCEDURES W/O CC 462 0.01
113: AMPUTATION FOR … CV DX 4,899 0.16
554: OTHER VASCULAR PROCEDURES W CC W/O MAJOR CV DX 5,388 0.17
555: PERCUTANEOUS CARDIOVASCULAR … PROC W DRUG-ELUTING STENT W MAJOR CV DX 16,412 0.53
558: PERCUTANEOUS CARDIOVASCULAR PROC W DRUG-ELUTING … procedures 3,105 0.07
63: Other non-OR therapeutic cardiovascular procedures 11,123 0.27
64: Bone
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-disposition-120516.pdf
October 01, 2011 - company dedicated to the
research and development of new medicines in
therapeutic areas including cardiovascular … ,
starting line 41) states “many trials, but almost exclusively in
patients receiving aspirin for cardiovascular … and bone
fractures (8) - Increased incidence of infectious
processes (9) - Increased incidence of
cardiovascular … diseases, effect that may
potentiate the cardiovascular ADEs of NSAIDs. … Proton-pump inhibitors are associated with
increased cardiovascular risk independent of
clopidogrel
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2024-11/uspstf-annual-report-congress-2024.pdf
January 01, 2024 - start
screening due in part to the increased incidence in younger age groups
• Aspirin use to prevent cardiovascular … Counseling
to Promote Healthy
Lifestyle and/or Weight
Loss in Adults
Enhanced Risk
Assessment for
Cardiovascular … Speech & Language Delay
& Disorders in Children
Draft
Research Plan
Enhanced Risk
Assessment for
Cardiovascular … Report to Congress on High-Priority
Evidence Gaps for Clinical Preventive Services
Health equity in cardiovascular … Evidence Gaps for Clinical Preventive Services
Recent evidence gaps related to cancer
prevention and cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/venous-thromboembolism-1.pdf
March 01, 2020 - Aspirin is an antiplatelet, and while there are other antiplatelets used for other
cardiovascular conditions … OR
"Postoperative Complicati
on*" OR
"Perioperative Care Metho
ds" OR Operation)))
NOT
((MH
"Cardiovascular … Diseases"
OR Heart) OR (AB
"Cardiovascular Disease*"
OR Heart OR Cardiac)))
((((MH
"Aspirin/Therapeutic … OR
"Postoperative Complicati
on*" OR
"Perioperative Care Metho
ds" OR Operation)))
NOT
((MH
"Cardiovascular … Diseases"
OR Heart) OR (AB
"Cardiovascular Disease*"
OR Heart OR Cardiac)))
Making Healthcare Safer
-
hcup-us.ahrq.gov/reports/natstats/his96/table2.pdf
February 11, 2011 - $10,450 $19,649 $35,666 10.9 3.6 64.0 51.3
respiratory system [42.]
7 Operations on the cardiovascular … 116,557 0.33 $31,743 $9,597 $18,143 $35,290 8.5 5.5 52.0 59.2
7.20 Other diagnostic cardiovascular … $7,346 $11,199 $17,466 5.4 0.9 55.3 61.5
procedures [62.]
7.21 Other non-OR therapeutic cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/worker-health_research-protocol.pdf
May 26, 2015 - Health and safety outcomes (e.g., cardiovascular events or incidence of work-
related injuries)
Source … o KQ 2a: Health and safety outcomes: Mortality; incidence of injuries,
cardiovascular disease or cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Additionally, patients with chronic hyperuricemia have an increased risk of
cardiovascular disease, … However, better gout management could reduce hospitalizations and renal or
cardiovascular complications
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_3-user-guide-to-ocer_130129.pdf
September 21, 2012 - example of a prediction model is by Dorresteijn
et al., who predicted the effect of rosuvastatin on
cardiovascular … scores), as
well as a prediction model developed using the trial
data to calculate baseline risk of cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_10-user-guide-to-ocer_130129.pdf
January 01, 2011 - Ray and colleagues39 reported
effect modification by cardiovascular disease risk,
derived and summarized … Adjustment for multiple cardiovascular risk
factors using a summary risk score.
-
effectivehealthcare.ahrq.gov/products/health-equity-preventive/research
-
effectivehealthcare.ahrq.gov/products/type-2-diabetes-medications-update/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
February 01, 2018 - Rosiglitazone evaluated for cardiovascular
outcomes in oral agent combination therapy
for type 2 diabetes … Cardiovascular safety of non-steroidal anti-
inflammatory drugs: network meta-analysis. … One considered frequently is major adverse
cardiovascular events. … Statin Monotherapy: An
Update
Johns Hopkins University,
2014
Adults with moderate or
high cardiovascular
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening
May 18, 2021 - The USPSTF has a recommendation statement on aspirin use to prevent cardiovascular disease and colorectal … Recommendations
The USPSTF has a recommendation statement on aspirin use for the primary prevention of cardiovascular … measure for the burden of screening), and resulting harms from colonoscopy (ie, gastrointestinal and cardiovascular … Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-fullreport.pdf
February 01, 2018 - example, a measure
addressing childhood obesity may have implications for the subsequent development
of cardiovascular … Severe sepsis includes sepsis plus one of the following clinical states: cardiovascular organ
dysfunction … Septic shock is defined as sepsis and cardiovascular dysfunction (Goldstein, et al., 2005;
Rivers, Ahrens … Shock occurs when the
cardiovascular system is unable to provide energy resources (oxygen and glucose
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-fullreport.pdf
May 01, 2018 - example, a measure
addressing childhood obesity may have implications for the subsequent development
of cardiovascular … Severe
sepsis includes sepsis plus one of the following clinical states: cardiovascular organ dysfunction … Septic shock is defined as sepsis and cardiovascular dysfunction
(Goldstein, et al., 2005; Rivers, Ahrens … Shock
occurs when the cardiovascular system is unable to provide energy resources (oxygen and
glucose
-
hcup-us.ahrq.gov/reports/methods/2007_04.pdf
January 01, 2007 - System 1,066,769 11.0 220,143 3.0
Eye 767,584 7.9 134,544 1.9
Nervous System 678,902 7.0 147,181 2.0
Cardiovascular … CPT
CCS Classification Available through the HCUP Central Distributor, 2004 SASD
(continued)
Cardiovascular … or spinal stimulator and injection into spinal canal 0.576
4 63 63: Other non-O.R. therapeutic cardiovascular … Other therapeutic procedures 1.400
7 62 62: Other diagnostic cardiovascular
-
hcup-us.ahrq.gov/reports/methods/2011_01.pdf
January 01, 2011 - Circulation: Cardiovascular Quality and Outcomes. 2008 Sep;1(1):29-
37. … Circulation: Cardiovascular Quality and Outcomes. 2009 Sep;2(5):407-13. … Elderly women have lower rates of stroke,
cardiovascular events, and mortality after hospitalization … Circulation: Cardiovascular
Quality and Outcomes. 2009 Nov;2(6):558-65.